anti-Fgl-2 MAb (TTI)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Nameanti-Fgl-2 MAb (TTI)
Drug Alias NameFgl2 MAb
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCoagulation factor inhibitors
TargetsCoagulation factor
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrillium Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrillium Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsHepatitis CHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A